BG108932A - Фармацевтичен състав, съдържащ арсенит, за лечение на злокачествени образувания - Google Patents

Фармацевтичен състав, съдържащ арсенит, за лечение на злокачествени образувания

Info

Publication number
BG108932A
BG108932A BG108932A BG10893204A BG108932A BG 108932 A BG108932 A BG 108932A BG 108932 A BG108932 A BG 108932A BG 10893204 A BG10893204 A BG 10893204A BG 108932 A BG108932 A BG 108932A
Authority
BG
Bulgaria
Prior art keywords
treatment
tumour
arsenite
pharmaceutical composition
malignancy
Prior art date
Application number
BG108932A
Other languages
English (en)
Other versions
BG66356B1 (bg
Inventor
Sang Lee
Yong Yang
Original Assignee
Komipharm International Co., Ltd
Sang Lee
Yong Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29244880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG108932(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Komipharm International Co., Ltd, Sang Lee, Yong Yang filed Critical Komipharm International Co., Ltd
Publication of BG108932A publication Critical patent/BG108932A/bg
Publication of BG66356B1 publication Critical patent/BG66356B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Изобретението се отнася до фармацевтичен състав за лечение на твърди злокачествени образувания като тумор на кръговидното черво, стомашен тумор, тумор на млечната жлеза, тумор на яйчника, тумор на простатата и тумор на бъбрека. Съставът съдържа сол на мета-арсенит (AsO2-) и фармацевтично приемлива добавка. Изобретението се отнася също до използването му и до метод за лечение.
BG108932A 2002-04-10 2004-11-09 Фармацевтичен състав, съдържащ арсенит, за лечението на злокачествени образувания BG66356B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2002/000231 WO2003086424A1 (en) 2002-04-10 2002-04-10 Pharmaceutical composition comprising arsenite for the treatment of malignancy

Publications (2)

Publication Number Publication Date
BG108932A true BG108932A (bg) 2005-11-30
BG66356B1 BG66356B1 (bg) 2013-09-30

Family

ID=29244880

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108932A BG66356B1 (bg) 2002-04-10 2004-11-09 Фармацевтичен състав, съдържащ арсенит, за лечението на злокачествени образувания

Country Status (25)

Country Link
US (1) US20050106262A1 (bg)
EP (2) EP1496918B1 (bg)
JP (1) JP2005525397A (bg)
CN (1) CN1298332C (bg)
AP (1) AP2004003167A0 (bg)
AU (2) AU2002253713B2 (bg)
BG (1) BG66356B1 (bg)
BR (1) BR0215689A (bg)
CA (1) CA2481602C (bg)
CY (1) CY1114422T1 (bg)
DK (2) DK2042182T3 (bg)
EC (1) ECSP045408A (bg)
ES (2) ES2425418T3 (bg)
FI (1) FI1496918T3 (bg)
HU (1) HU230851B1 (bg)
IL (2) IL164470A0 (bg)
LT (1) LT1496918T (bg)
MX (1) MXPA04009898A (bg)
NO (1) NO335317B1 (bg)
NZ (1) NZ536452A (bg)
PT (2) PT2042182E (bg)
RO (1) RO123269B1 (bg)
TN (1) TNSN04198A1 (bg)
UA (1) UA80426C2 (bg)
WO (1) WO2003086424A1 (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789029A2 (en) * 2004-08-30 2007-05-30 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
US20100249210A1 (en) * 2008-09-30 2010-09-30 Michael Bastiani Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
CN102060722B (zh) * 2009-05-01 2014-06-11 常州高新技术产业开发区三维工业技术研究所有限公司 一种含砷化合物及其制备方法和用途
MX2012002855A (es) * 2009-09-10 2012-07-20 Kominox Inc Terapia de cancer dirigida a celula madre de cancer y resistente a farmaco.
MX2012002922A (es) * 2009-09-18 2012-09-07 Kominox Inc Metodos para tratar tumores del cerebro.
CN101695501B (zh) * 2009-10-10 2013-08-14 广汉恒宇新材料有限公司 一种纳米尺寸亚砷酸的壳聚糖包载体及其制造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804928B1 (en) * 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
PT2018858E (pt) * 1997-10-15 2011-03-24 Polarx Biopharmaceuticals Inc Composições e métodos para o tratamento de doenças neoplásicas primárias e metastáticas usando compostos de arsénio
CN1119152C (zh) * 1998-08-02 2003-08-27 哈尔滨医科大学第一临床医学院 治疗消化系统肿瘤注射液及其应用

Also Published As

Publication number Publication date
AP2004003167A0 (en) 2004-12-31
AU2002253713B2 (en) 2008-09-18
CN1298332C (zh) 2007-02-07
RO123269B1 (ro) 2011-05-30
CY1114422T1 (el) 2016-08-31
HU230851B1 (en) 2018-09-28
JP2005525397A (ja) 2005-08-25
LT1496918T (lt) 2023-05-25
NO20044573L (no) 2004-10-22
IL164470A0 (en) 2005-12-18
MXPA04009898A (es) 2005-06-20
EP2042182A1 (en) 2009-04-01
PT2042182E (pt) 2013-08-28
EP1496918B1 (en) 2023-02-08
FI1496918T3 (fi) 2023-05-11
DK2042182T3 (da) 2013-08-26
BG66356B1 (bg) 2013-09-30
CA2481602C (en) 2011-06-21
ES2425418T3 (es) 2013-10-15
BR0215689A (pt) 2005-02-01
ES2944907T3 (es) 2023-06-27
AU2008255139B2 (en) 2013-10-03
AU2002253713A1 (en) 2003-10-27
EP1496918A1 (en) 2005-01-19
DK1496918T3 (da) 2023-05-15
TNSN04198A1 (en) 2007-03-12
HUP0500199A2 (en) 2007-02-28
CA2481602A1 (en) 2003-10-23
NZ536452A (en) 2007-06-29
UA80426C2 (en) 2007-09-25
HUP0500199A3 (en) 2008-03-28
US20050106262A1 (en) 2005-05-19
EP2042182B1 (en) 2013-05-22
CN1625407A (zh) 2005-06-08
NO335317B1 (no) 2014-11-10
PT1496918T (pt) 2023-05-25
AU2008255139A1 (en) 2009-01-08
WO2003086424A1 (en) 2003-10-23
IL164470A (en) 2010-12-30
ECSP045408A (es) 2006-03-01

Similar Documents

Publication Publication Date Title
IL258880A (en) Compounds of diarylhydantoin
WO2003002595A3 (en) Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
WO2006044826A3 (en) Thiophens and their use as anti-tumor agents
HK1061199A1 (en) Pharmaceutical compositions comprising arsenic trioxide for the treatment of multiple myeloma
HK1131165A1 (zh) 幫助調控血管生成、抑制轉移和腫瘤纖維化以及評估結腸癌腫瘤的惡性程度的藥物組合物及方法
SG170809A1 (en) Diarylthiohydantoin compounds
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
WO2006044975A3 (en) Compositions and their use as anti-tumor agents
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
HK1155664A1 (en) Treatment of metastasized tumors
BG108932A (bg) Фармацевтичен състав, съдържащ арсенит, за лечение на злокачествени образувания
WO2005016958A3 (en) Compounds for treating tumors
IL160382A0 (en) Use of 4-pyridylmethylphthalazines for cancer treatment
UA87292C2 (ru) Применение сирамезина для лечения злокачественных опухолей
UA49216A (uk) Засіб для лікування ускладнень після видалення злоякісних новоутворень шкіри
NZ620368A (en) Diarylhydantoin compounds